• Iran’s supreme leader, Ayatollah Ali Khamenei, blamed the country’s “enemies” today for the protests, his first comments since the unrest started.
New year, new confidence
• A wave of optimism in American businesses is bringing investment in new plants, equipment and factory upgrades that could create jobs — and perhaps raise wages.
Initially inspired by the Trump administration’s regulatory pullback, executives are also encouraged by continued economic growth.
• “The notion that deregulation unleashes growth is virtually impossible to find in the data,” said a onetime economic adviser to former Vice President Joe Biden. “What does matter is this idea that confidence matters. If their expectations about the future are positive, then it does make a difference.”
• Millions of people in the U.S. have fallen victim to painkiller abuse, alcoholism, the rise of meth and the revival of heroin. As a result, entrepreneurs are sweeping in.
Our multipart series examines the industry of addiction treatment, which is haphazardly regulated, poorly understood and expanding at a rapid clip.
• In the first installment, we look at one of the biggest addiction-treatment companies in the country, and how the death of a patient nearly brought it down.
A note from our new publisher
• Addressing readers of The Times, A. G. Sulzberger explains his approach to the job in a period when “misinformation is rising and trust in the media is declining.” Read his comments here.
• He’ll also be answering readers’ questions. Submit yours.
Listen to ‘The Daily’: How the Russia Inquiry Began
A low-level adviser to the Trump campaign let something slip over drinks. The result is an investigation that has cast a shadow over President Trump’s first year in office.
• Rupert Murdoch’s decision to sell most of 21st Century Fox to Disney has many wondering what the future holds for him and two sons.
• Our DealBook columnist, Andrew Ross Sorkin, looks at the biggest deals of 2017, and the year’s big winners.
• Fungi could play a role in…